Financials data is unavailable for this security.
View more
Year on year Biodesix Inc grew revenues 28.46% from 38.21m to 49.09m while net income improved from a loss of 65.45m to a smaller loss of 52.15m.
Gross margin | 77.58% |
---|---|
Net profit margin | -73.08% |
Operating margin | -55.09% |
Return on assets | -46.01% |
---|---|
Return on equity | -304.17% |
Return on investment | -60.16% |
More ▼
Cash flow in USDView more
In 2023, cash reserves at Biodesix Inc fell by 16.80m. Cash Flow from Financing totalled 29.13m or 59.34% of revenues. In addition the company used 22.87m for operations while cash used for investing totalled 23.06m.
Cash flow per share | -0.4034 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.2498 |
---|---|
Tangible book value per share | 0.0988 |
More ▼
Balance sheet in USDView more
Current ratio | 3.28 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.9885 |
---|---|
Total debt/total capital | 0.4971 |
More ▼